EGFR mutation is a key genetic alteration in non-small cell lung cancer (NSCLC), with mutation rate as high as 30% among NSCLC patients and approximately 16% among those with advanced lung adenocarcinoma (27). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.